| 000 | 01365 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514072218.0 | ||
| 264 | 0 | _c20030916 | |
| 008 | 200309s 0 0 eng d | ||
| 022 | _a0269-2813 | ||
| 024 | 7 |
_a10.1046/j.1365-2036.2003.01574.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArnott, I D R | |
| 245 | 0 | 0 |
_aAn analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cJun 2003 |
||
| 300 |
_a1451-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aIntestinal Fistula _xetiology |
| 650 | 0 | 4 | _aLong-Term Care |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMcNeill, G | |
| 700 | 1 | _aSatsangi, J | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 17 _gno. 12 _gp. 1451-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2036.2003.01574.x _zAvailable from publisher's website |
| 999 |
_c12606321 _d12606321 |
||